Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pathophysiology, Mitigation, and a Core Outcome Set for the Empty Pelvis Syndrome After Pelvic Exenteration: a Delphi-study by the PelvEx Collaborative

NCT05683795 is registered in ClinicalTrials.gov with University of Southampton as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05683795 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pathophysiology, Mitigation, and a Core Outcome Set for the Empty Pelvis Syndrome After Pelvic Exenteration: a Delphi-study by the PelvEx Collaborative
Lead sponsor
University of Southampton
Phase
Observational
Overall status
Unknown status
Start date
January 3, 2023
Completion date
August 31, 2023
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

empty pelvis syndrome, pelvic cancer, pelvic exenteration, pelvic neoplasm, postoperative complications, rectal cancer